Nowadays quantitative chemical analysis is usually costly, instrument-dependent, and time-consuming, which limits its implementation for remote locations and resource-limited regions. Inspired by the ancient papercutting art (), we herein introduce a novel cut-and-paste protocol to fabricate 3D microfluidic paper-based analytical devices (μPADs) that are suitable for on-site quantitative assay applications. The preparation of the device is fast, simple, and independent of any lithographic devices or masks. Particularly designed reaction "channels" were pre-cut from a piece of filter paper, then assembled back to the silanized, superhydrophobic paper pads. The different layers of the device were assembled using a chemically-inert adhesive spray. The fabricated device has high efficiency of liquid handling (up to 60 times faster than conventional methods) and it is particularly inexpensive. Beyond the benchtop fabrication advantage, in conjunction with a custom mobile app developed for colorimetric analysis, we were able to quantify representative environmental contaminants (, the amount of Cr(vi) and nitrite ions) in various water samples with the cut-and-paste μPADs (namely kPADs). Their detection limits (0.7 μg mL for Cr(vi) and 0.4 μg mL for nitrite ions, respectively) are comparable with conventional spectrophotometric methods, which confirm the potential of kPADs for on-site environmental/sanitary monitoring and food toxin pre-screening.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067308PMC
http://dx.doi.org/10.1039/c9ra04014eDOI Listing

Publication Analysis

Top Keywords

mobile app
8
nitrite ions
8
three-dimensional paper-based
4
paper-based micro-analytical
4
device
4
micro-analytical device
4
device cut-and-paste
4
cut-and-paste fabrication
4
fabrication mobile
4
app quantitation
4

Similar Publications

Introduction: The escalating resistance of microorganisms to antimicrobials poses a significant public health threat. Strategies that use biomarkers to guide antimicrobial therapy-most notably Procalcitonin (PCT) and C-reactive protein (CRP)-show promise in safely reducing patient antibiotic exposure. While CRP is less studied, it offers advantages such as lower cost and broader availability compared with PCT.

View Article and Find Full Text PDF

Background:  Digital health interventions targeting behavior change are promising in adults and adolescents; however, less attention has been given to younger children. The proliferation of wearables, such as smartwatches and activity trackers, that support the collection of and reflection on personal health data highlights an opportunity to consider novel approaches to supporting health in young children (aged 5-11 y).

Objective:  This review aims to investigate how smartwatches and activity trackers have been used across child health interventions (for children aged 5-11 y) for different health areas, specifically to identify the population characteristics of those being targeted, describe the characteristics of the devices being used, and report the feasibility and acceptability of these devices for health-related applications with children.

View Article and Find Full Text PDF

Background: Advancements in mobile technology have paved the way for innovative interventions aimed at promoting physical activity (PA).

Objective: The main objective of this feasibility study was to assess the feasibility, usability, and acceptability of the More In Action (MIA) app, designed to promote PA among older adults. MIA offers 7 features: personalized tips, PA literacy, guided peer workouts, a community calendar, a personal activity diary, a progression monitor, and a chatbot.

View Article and Find Full Text PDF

Background: Evidence-based digital therapeutics represent a new treatment modality in mental health, potentially providing cost-efficient, accessible means of augmenting existing treatments for chronic mental illnesses. CT-155/BI 3972080 is a prescription digital therapeutic under development as an adjunct to standard of care treatments for patients 18 years of age and older with experiential negative symptoms (ENS) of schizophrenia. Individual components of CT-155/BI 3972080 are designed based on the underlying principles of face-to-face treatment.

View Article and Find Full Text PDF

Background: Insomnia is a prevalent sleep disorder affecting millions worldwide, with significant impacts on daily functioning and quality of life. While traditionally assessed through subjective measures such as the Insomnia Severity Index (ISI), the advent of wearable technology has enabled continuous, objective sleep monitoring in natural environments. However, the relationship between subjective insomnia severity and objective sleep parameters remains unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!